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Background: Laparoscopic adhesiolysis is emerging as an alternative for open surgery in adhesive small bowel
obstruction. Retrospective studies suggest that laparoscopic approach shortens hospital stay and reduces complications
in these patients. However, no prospective, randomized, controlled trials comparing laparoscopy to open surgery have
been published.
Methods/Design: This is a multicenter, prospective, open label, randomized, controlled trial comparing laparoscopic
adhesiolysis to open surgery in patients with computed-tomography diagnosed adhesive small bowel obstruction that
is not resolving with conservative management. The primary study endpoint is the length of postoperative hospital stay
in days.
Sample size was estimated based on preliminary retrospective cohort, which suggested that 102 patients would provide
80% power to detect a difference of 2.5 days in the length of postoperative hospital stay with significance level of 0.05.
Secondary endpoints include passage of stool, commencement of enteral nutrition, 30-day mortality, complications,
postoperative pain, and the length of sick leave. Tertiary endpoints consist of the rate of ventral hernia and the
recurrence of small bowel obstruction during long-term follow-up. Long-term follow-up by letter or telephone
interview will take place at 1, 5, and 10 years.
Discussion: To the best of our knowledge, this trial is the first one aiming to provide level Ib evidence to assess
the use of laparoscopy in the treatment of adhesive small bowel obstruction.
Trial registration: ClinicalTrials.gov identifier: NCT01867528. Date of registration May 26th 2013.Background
Small bowel obstruction (SBO) is a common surgical emer-
gency most frequently caused by adhesions. A large portion
of adhesive SBO resolve by nonoperative methods such as
fasting and ingestion of an oral contrast-media, while a sig-
nificant number of patients will need emergency surgery
[1]. For decades open surgery has been the gold standard in
treating adhesive SBO. Now that laparoscopic surgery has
been established as a first line option in many elective
indications such as colorectal surgery, fundoplication,
and cholecystectomy for example, laparoscopy is emer-
ging also as a viable alternative in emergency surgery.* Correspondence: ville.sallinen@helsinki.fi
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unless otherwise stated.If SBO is caused by one adhesive band, the surgical
treatment is straightforward - cutting the band causing
obstruction. Laparoscopic approach seems ideal for such
a procedure, preventing the morbidity of a laparotomy
incision. First publications describing laparoscopic adhe-
siolysis in SBO are from the 1990’s [2]. Since then several
retrospective series have been published, and a recent
meta-analysis pooled patients from four studies, including
a total of 334 patients [3]. Meta-analysis showed that
patients treated by the laparoscopic approach had less
complications, and faster return of bowel function [3].
However, there are no prospective randomized trials
comparing open approach to laparoscopy. Furthermore,
previous retrospective studies have a selection bias be-
cause the easiest cases are selected for laparoscopic ap-
proach. One of the drawbacks of laparoscopic approachl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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port, the rate of bowel lesion in laparoscopic adhesioly-
sis was 6.6%, and only 84% were detected during the
operation [4].
Methods/Design
Objective
The objective of this trial is to compare open surgery
to laparoscopic adhesiolysis in patients with computed
tomography-diagnosed adhesive SBO that is not resolved
by nonoperative means. The hypothesis is that laparo-
scopic approach shortens the length of hospital stay with-
out increasing complications.
Ethics and permissions
This study will be conducted in accordance with the prin-
ciples of the Declaration of Helsinki and ‘good clinical
practice’ guidelines. The research plan has been evaluated
and approved by the local institutional ethics committee
of the main research center (Helsinki University Central
Hospital, Ethics Committee, Department of Surgery). The
research plan has further been approved by each par-
ticipating centers’ institutional review board (Helsinki
University Central Hospital, Vaasa Central Hospital, Turku
University Hospital, Oulu University Hospital, Tampere Uni-
versity Hospital, Päijät-Häme Central Hospital). CONSORT
2010 checklist is shown in Additional file 1.
Patient evaluation and selection
Patients with computed tomography-confirmed SBO will
be eligible for the study. If no exclusion criteria are present,
nasogastric tube is inserted and the patient is admitted
to the emergency surgery ward. If the obstruction does
not resolve within 12 hours, an oral water-soluble contrast
(Gastrografin®) is used. If the contrast has not advanced
to the colon within 8 hours and the patient has no signs
of spontaneous resolution of obstruction, surgical inter-
vention is considered necessary and the patient is ran-
domized to either open or laparoscopic surgery. The oral
water-soluble contrast study has been shown to have 97%
sensitivity and 96% specificity in predicting nonoperative
resolution of adhesive SBO [5]. Patients can alternatively
undergo nonoperative management by fasting and naso-
gastric tube only if oral water-soluble contrast is contrain-
dicated or not available. If SBO in these patients is not
resolved within 48 hours, they are included in the study
(Figure 1).
Inclusion criteria:
– All patients with clinical and computed
tomography-diagnosed adhesive small bowel
obstruction
– Obstruction is not relieved by conservative methods
(nasogastric tube, nil per os) including Gastrografin®is not passed to colon within 8 hours (48-hour
conservative treatment without Gastrografin® is
allowed if Gastrografin® is contraindicated
(e.g. allergy) or not available)
Exclusion criteria:
– Strong suspicion of strangulation or clinical
peritonitis requiring an urgent operative
intervention
– Previously confirmed or strongly suspected
peritoneal carcinosis
– Previously confirmed wide diffuse adhesions of the
abdominal cavity
– Previous open surgery for endometriosis
– Previous generalized peritonitis (not including local
peritonitis such as appendicitis)
– Active abdominal malignancy or remission of less
than 10 years’ duration
– Previous radiotherapy of the abdominal region
– Previous obesity surgery
– 3 or more earlier open abdominal operations
(not including caesarean section(s))
– Suspicion of other cause for obstruction than
adhesions in CT-scan
– Recent abdominal operation (within 30 days)
– Previous laparotomy for aorta or iliac vessels
– Crohn's disease
– Anesthesiological contraindication for laparoscopy
– No informed consent
– Age less than 18 years or over 95 years
– Pregnancy
– Patient living in institutionalized care (such as
health centre ward), not including retirement
homes
– A hospital stay of more than one week prior to
surgical consultationRandomization procedure
Patients are randomly allocated (1:1) to either laparo-
scopic or open surgery. Randomization is done using
block randomization with randomly varying block size
(2–6) stratified by each study center. Cards with partic-
ipants’ randomization number and randomization group
are sealed within numbered envelopes. Randomization and
sealing within envelopes is done at the main research cen-
ter (Helsinki) and letters are sent to each participating cen-
ter at the beginning of the trial. The envelope is opened
only after patient fulfills inclusion criteria, none of the
exclusion criteria are met, and patient has agreed to
participate in the study and has given a written consent.
Envelopes are opened in numerical order. Operation is
scheduled after randomization.
Figure 1 Flowchart of patients in the trial. CT - computed tomography, NGT - nasogastric tube, NPO - nil per os, SBO - small bowel obstruction.
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Pre- and perioperative treatment
Fluid balance and electrolyte disturbancies are corrected.
Prophylactic cefuroxime 1500 mg and metronidazole 500
mg are administered intravenously just before the incision.
An epidural catheter may be placed if recommended by the
anesthesiologist. A nasogastric tube is inserted.
Laparoscopic technique
The first port is inserted using open approach or by using
an optic port. Subsequent ports are inserted under direct
vision. The location of the ports is left to the surgeons dis-
cretion. The abdominal cavity is inspected and the caecum
located and identified. Laparoscopic forceps are used to
examine the small bowel starting from the terminal ileum
until the transition site is identified. Dilated small bowel
loops are not grasped, but can be mobilized by grasping
the mesenterium. Once the transition site is identified,
the obstructing adhesions are divided and the bowel is
inspected for vitality. Ports are removed under vision,and possible bleeding is primarily controlled by ligatures.
The fascial holes of ports over 5 mm are closed. A naso-
gastric tube is left in place.
Criteria for conversion to open surgery
– Confirmed or suspected small bowel perforation,
which is not amenable for laparoscopic suturing
– A transition site is not identified
– The reason for obstruction is not found
– Peritoneal carcinosis is detected
– The presence of widespread diffuse adhesions
– Need for bowel resection - conversion can be made to
minilaparotomy to exteriorize the small bowel section
requiring resection
Open surgical technique
A midline incision is made and the abdominal cavity is
inspected. The small bowel is examined until the transition
site is located. Adhesions causing obstruction are divided.
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stomach and the stomach is emptied using a nasogastric
tube. The fascia is closed using continuous or interrupted
sutures at surgeon’s discretion.
Postoperative treatment
The nasogastric tube is kept in place until the secretion
is less than 500 ml per 8 hours. After the removal of the
nasogastric tube, the patient can drink up to 200 ml per
6 hours. If no nausea develops, patient may drink freely.
Proton pump inhibitors are used for the length of the
hospital stay. Trombosis profylaxis is commenced 6 hours
after surgery, if there is no suspicion of postoperative
hemorrhage. Ibuprofen, paracetamol, tramadol, and oxy-
codone can be used for pain. Pain is evaluated using a
visual analogue scale daily and before administering pain
killers.
Criteria for discharge
– Passage of stool
– The patient tolerates per oral nutrition
– Sufficient pain relieve is achieved with ibuprofen,
paracetamol, and/or tramadol.
Unresolving obstruction after surgery
If the obstruction if not resolved in spite of surgical treat-
ment, the patient can undergo radiological imaging studies
and/or surgical exploration (open or laparoscopic) at the
discretion of the surgeon.
Surgeons
The same surgeons perform both open and laparoscopic
operations. All participating surgeons must have solid ex-
perience and skills of complex laparoscopic procedures,
and need to have perfomed at least two laparoscopic adhe-
siolysis for small bowel obstruction before operating on
patients participating in the trial.
Follow-up
Patients of working age are given sick leave. The length
of sick leave is at the discretion of treating physician, who
is taking into consideration the patient’s age and type of
work (physical or desk job). A follow-up call in scheduled
within 30 days, and return to work, possible late complica-
tions and readmissions are registered. Follow-up question-
naires are sent 1, 5 and 10 years after the randomization,
and in case of no response, patients are contacted by tele-
phone. Information about possible hernias and recurrent
bowel obstructions is solicited.
Primary endpoint
– Length of post-operative hospital stay (days)Secondary endpoints
– Passage of stool (post-operative days)
– Commencement of enteral nutrition (post-operative
days)
– 30-day mortality
– Complications (all causes), graded by Clavien-Dindo
classification
– Number of participants with iatrogenic small bowel
lesions
– Number of participants with readmission(s)
– Number of participant with failure to resolve
obstruction
– Pain scores on the Visual Analog Scale
– Length of epidural catheter analgesia (days)
– Total need of opioids in milligrams
– Length of sick leave (days)
– Conversion rate (laparoscopic group)
Tertiary endpoints
– Number of participants who develop ventral hernia
– Number of patient with recurrent adhesive small
bowel obstruction
Data collection and analysis
Data will be collected by using an electronical case report
form, and statistically analyzed in the main research center
(Helsinki) once the trial is completed. Continuous variables
will be compared using t-test or Mann–Whitney-U-test.
Categorical variables will be compared using Fischer’s
exact-test or Chi-square-test. Groups will be analyzed
as intention-to-treat. An interim analysis will be made
when 52 patients have been randomized and treated.
Sample size calculation
Based on preliminary retrospective analysis on laparoscopic
and open adhesiolysis we have estimated the standard devi-
ation to be 3.75 days in laparoscopic group and 5 days in
open surgery group. Sample size is calculated to be able to
demostrate 2.5 day difference in the post-operative length
of stay. 102 patients are needed to achieve 80% power with
a significance level of 0.05.
Registration
This trial has been registered at ClinicalTrials.gov (Identi-
fier: NCT01867528).
Discussion
While laparoscopy has become the treatment-of-choice in
acute cholecystitis, acute appendicitis, and perforated pep-
tic ulcer, there are still areas of emergency surgery that are
under debate [6,7]. It has been suggested that purulent
peritonitis caused by acute diverticulitis can be treated by
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their way to either prove or disprove this approach [9,10].
As laparoscopic surgery is becoming more common in
emergency surgery, adhesive SBO is the obvious next tar-
get for a laparoscopic approach [1]. Although there are
several retrospective series, and meta-analyses comparing
open approach to laparoscopy, there are no prospective,
randomized studies. A search for ongoing trials reveals that,
except for this trial, there are no other prospective, ran-
domized trials enrolling patients at the moment of writing.
Although previous retrospective series have shown associ-
ation of less complications and shorter hospital stay with
the laparoscopic approach, all previous retrospective series
are more or less biased as the easiest cases are selected for
laparoscopic approach.
This trial aims to provide level Ib evidence for the use
of laparoscopy in the treatment of adhesive SBO that is
not resolving by conservative means. Two large meta-
analyses have shown that the advancement of oral contrast
agent (Gastrografin) to the colon predicts that the obstruc-
tion would resolve with 0.97 sensitivity and 0.96 speficity
[5,11]. Optimal timing of the abdominal radiograph to pre-
dict the success of nonoperative management is unknown
[5]. In this study, the sensitivity, specificity, positive and
negative likelihood ratios for waiting 4–8 hours were simi-
lar to waiting 24 hours before abdominal radiograph is car-
ried out [5,11]. Thus, there appears to be no advantage of
waiting more than 4–8 hours. In this trial, if the oral
contrast agent is not detected in the colon after 8 hours
the conservative management is considered a failure and
operative management is warranted. Further, the intestine
is decompressed using a nasogastric tube for a minimum
of 12 hours before commencing the oral contrast agent
study. Thus, in total, the nonoperative management trial
takes at minimum 20 hours.
Because there are several exclusion criteria in this trial,
the patients are selected, and the results will not be ap-
plicable to all patients presenting with an adhesive SBO.
These exclusion criteria, however, should not be regarded as
absolute contraindications for laparoscopic approach. Many
of the exclusion criteria are relative contraindications
(peritonitis, suspicion of other cause than adhesions,
pregnancy, wide diffuse adhesions, peritoneal carcinosis) or
predictors of failure of laparoscopic approach (endometri-
osis, earlier generalized peritonitis, over 3 open procedures,
radiotherapy, vascular procedures) [12]. Furthermore,
earlier obesity surgery is an indication for laparoscopic
approach, and these patients are excluded because we
do not think it is ethical to randomize them for open
approach. Some of the exclusion criteria (age >95 years,
earlier abdominal surgery within 30 days, patient living in
an institutional care, or prior hospital stay of over 1 week)
were included to reduce the morbidity of the patients in-
cluded in the study, as inclusion of a few of these patientsin one of the arms would create a strong bias (i.e. the
length of stay would be longer because of the morbidity of
the patients, not because of the approach used).
The trial has been recruiting since summer 2013. Enroll-
ment of the patients is estimated to last for 4–5 years and
primary end-point results are estimated to be available in
2018.
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